BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Drug Development

  EMPA-KIDNEY trial showed significant benefit of JARDIANCE (empagliflozin) in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people living with chronic kidney disease

  EMPA-KIDNEY Phase III clinical trial met its primary endpoint by demonstrating a significant kidney and cardiovascular benefit for people living with chronic kidney disease (CKD).

  November 4, 2022

   · 

  11 min read
• Policy

  FDA Roundup: November 4, 2022

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

  November 4, 2022

   · 

  3 min read
• Biotech Bay

  NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference

  NeuroPace, Inc., a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, announced it will be participating in the upcoming 4th Annual Wolfe Research Healthcare Conference.

  November 4, 2022

   · 

  1 min read
• AbCellera to Present at Upcoming Investor Conferences in November 2022

  AbCellera announced that executives from the Company will present at the following investor conferences.

  November 4, 2022

   · 

  1 min read
• Business

  National Kidney Foundation Appoints Prominent Marketing Expert to Board of Directors

  The National Kidney Foundation is proud to announce the appointment of Lynn Pina, Chief Marketing Officer of GeoBlue, to its National Board of Directors.

  November 4, 2022

   · 

  3 min read
• Health care providers to Canadian governments: this is our prescription for hope

  Canada’s health ministers have a golden opportunity next week to bring hope to Canadians and to 1.3 million health care workers from coast to coast to coast by charting a clear path of tangible action to help stabilize and begin rebuilding our struggling health systems.

  November 4, 2022

   · 

  4 min read
• Business

  Syneos Health Reports Third Quarter 2022 Results

  Syneos Health, the only fully integrated biopharmaceutical solutions organization, reported financial results for the three and nine months ended September 30, 2022.

  November 4, 2022

   · 

  27 min read
• Business

  Affimed to Report Third Quarter 2022 Financial Results & Corporate Update on November 15, 2022

  Affimed N.V. announced that it will release third quarter 2022 results and corporate update on Tuesday, November 15, 2022.

  November 4, 2022

   · 

  1 min read
• Genetown

  SOPHiA GENETICS to Participate in Upcoming November 2022 Investor Conferences

  SOPHiA GENETICS SA, a cloud-native software company in the healthcare space, announced the company will be participating in the following investor conferences.

  November 4, 2022

   · 

  1 min read
• Business

  ImmunoGen Reports Recent Progress and Third Quarter 2022 Financial Results

  ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, reviewed recent progress in the business and reported financial results for the quarter ended September 30, 2022.

  November 4, 2022

   · 

  11 min read